United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2019_register
executive
2019-11-13
article
Meeting of the National Clinical Care Commission
Notices
D09002ee1bdb6ab3f
D09002ee1bdb6ab96
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
The National Clinical Care Commission (the Commission) will conduct its fifth meeting on Friday, November 22, 2019. The Commission is charged to evaluate and make recommendations to the U.S. Department of Health and Human Services (HHS) Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to awareness and clinical care for complex metabolic or autoimmune diseases that result from issues related to insulin that represent a significant disease burden in the United States, which may include complications due to such diseases.
84 FR 61633
https://www.govinfo.gov/app/details/FR-2019-11-13/2019-24636
2019-24636
fr13no19-61
4150-32-P
https://www.govinfo.gov/app/details/FR-2019-11-13/2019-24636
https://www.govinfo.gov/content/pkg/FR-2019-11-13/html/2019-24636.htm
https://www.govinfo.gov/content/pkg/FR-2019-11-13/pdf/2019-24636.pdf
2 p.
61633
61634
84 FR 61633
Meeting of the National Clinical Care Commission; Federal Register Vol. 84, Issue
NOTICE
2019-24636
DEPARTMENT OF HEALTH AND HUMAN SERVICES
2019-11-22
4150-32-P
2019-24636
Notice.
The National Clinical Care Commission (the Commission) will conduct its fifth meeting on Friday, November 22, 2019. The Commission is charged to evaluate and make recommendations to the U.S. Department of Health and Human Services (HHS) Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to awareness and clinical care for complex metabolic or autoimmune diseases that result from issues related to insulin that represent a significant disease burden in the United States, which may include complications due to such diseases.
The meeting will take place on Friday, November 22, 2019, from 8:00 a.m. to approximately 4:00 p.m. Eastern Time (ET).
Linda Harris, Designated Federal Officer, National Clinical Care Commission, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Suite 420, Rockville, MD 20852. Email: OHQ@hhs.gov.
Meetings:
National Clinical Care Commission,
jennifer.gillissen@kauffmaninc.com
OHQ@hhs.gov
https://events.kauffmaninc.com/events/nccc5/
https://health.gov/hcq/national-clinical-care-commission.asp
Federal Register
Vol. 84, no. 219
Office of the Federal Register, National Archives and Records Administration
2019-11-13
continuing
daily
deposited
born digital
310 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2019-11-13
P0b002ee1a38c1f4a
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr13no19
https://www.govinfo.gov/app/details/FR-2019-11-13
https://www.govinfo.gov/content/pkg/FR-2019-11-13/pdf/FR-2019-11-13.pdf
https://www.govinfo.gov/content/pkg/FR-2019-11-13/xml/FR-2019-11-13.xml
fdlp
61517
61817
DGPO
2019-11-13
2023-04-28
FR-2019-11-13
machine generated
eng
FR
FR-2019-11-13
84
219